Athernal Bio
PrivateLast Round
VC Round
Oct 1, 2025
Total Funding Raised
$12,600
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Athernal Bio is a biotechnology company developing targeted immunotherapies for high-risk clonal haematopoiesis, a blood cancer precursor condition, with the goal of preventing cancer before it starts.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Athernal Bio Comparables
Compare Athernal Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novartis | 63% | |
| Bristol Myers Squibb | 61% | |
| Servier | 48% |
Athernal Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 1, 2025 | ||||
| Accelerator | May 30, 2024 |
Key People
Founding team and executive leadership
Athernal Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Accelerate@Babraham | Accelerator |
| Delin Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
$4.7M round led by Delin Ventures
Recent news
Latest coverage and updates
- receives_financingSep 9, 2026
Athernal Bio received financing of $948K in grant on Sep 9th '26.
- is_developingSep 9, 2026
Athernal Bio is developing targeted immunotherapies on Sep 9th '26.
Athernal Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Athernal Bio's valuation, stock price, and market status.
Is Athernal Bio a public or private company?
Athernal Bio is a private company.
What is the current stock price of Athernal Bio?
Athernal Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Athernal Bio worth (valuation)?
Valuation information for Athernal Bio is not publicly available.
Can I buy Athernal Bio stock?
Athernal Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Athernal Bio's last funding round?
Athernal Bio's most recent funding round was Seed on October 1, 2025.
Who are the main investors in Athernal Bio?
Key investors in Athernal Bio include Delin Ventures.
Will Athernal Bio IPO soon?
No public IPO plans have been announced for Athernal Bio.
How can I track Athernal Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Athernal Bio's secondary market activity and sign up for updates.